Mariona Suñol

4.6k total citations
64 papers, 1.2k citations indexed

About

Mariona Suñol is a scholar working on Neurology, Surgery and Genetics. According to data from OpenAlex, Mariona Suñol has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 16 papers in Surgery and 16 papers in Genetics. Recurrent topics in Mariona Suñol's work include Neuroblastoma Research and Treatments (20 papers), Glioma Diagnosis and Treatment (15 papers) and Ocular Oncology and Treatments (7 papers). Mariona Suñol is often cited by papers focused on Neuroblastoma Research and Treatments (20 papers), Glioma Diagnosis and Treatment (15 papers) and Ocular Oncology and Treatments (7 papers). Mariona Suñol collaborates with scholars based in Spain, Argentina and United States. Mariona Suñol's co-authors include Jaume Mora, Carmen de Torres, Cinzia Lavarino, Ángel M. Carcaboso, Nagore G. Olaciregui, Andrey Tvardovskiy, Eva Rodríguez, Nicolas Rapin, Itys Comet and Faizaan Mohammad and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mariona Suñol

62 papers receiving 1.2k citations

Peers

Mariona Suñol

NEURO

GENET

SURGE

Veena Rajaram United States

Paolo Nozza Italy

A. Guha United States

Vittoria Donofrio Italy

Massimo Brisigotti Italy

Winward Choy United States

Hayato Ikota Japan

Enrico Madon Italy

Andréï Tchirkov France

Masashi Tamaki Japan

Veena Rajaram United States

Mariona Suñol

784 ×1.4

240 ×0.8

NEURO

425 ×1.6

GENET

128 ×0.6

SURGE

273 ×1.6

Citations per year, relative to Mariona Suñol Mariona Suñol (= 1×) peers Veena Rajaram

Countries citing papers authored by Mariona Suñol

Since Specialization

Citations

This map shows the geographic impact of Mariona Suñol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariona Suñol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariona Suñol more than expected).

Fields of papers citing papers by Mariona Suñol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariona Suñol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariona Suñol. The network helps show where Mariona Suñol may publish in the future.

Co-authorship network of co-authors of Mariona Suñol

This figure shows the co-authorship network connecting the top 25 collaborators of Mariona Suñol. A scholar is included among the top collaborators of Mariona Suñol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariona Suñol. Mariona Suñol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castillo‐Ecija, Helena, Eva Rodríguez, Sara Pérez‐Jaume, et al.. (2023). Prognostic value of xenograft engraftment in patients with metastatic high‐risk neuroblastoma. Pediatric Blood & Cancer. 70(6). e30318–e30318. 2 indexed citations

Pérez‐Somarriba, Marta, Vicente Santa‐María López, Ofelia Cruz, et al.. (2023). Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors. JCO Precision Oncology. 7(7). e2200547–e2200547. 2 indexed citations

Cruz, Ofelia, Sara Pérez‐Jaume, Vicente Santa‐María López, et al.. (2023). Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center. SHILAP Revista de lepidopterología. 2. 100115–100115. 4 indexed citations

Torner, Ferrán, et al.. (2022). Total calcaneal allograft reconstruction of an Ewing's sarcoma in a child: Outcome and review of the literature. Cancer Reports. 5(9). e1626–e1626. 5 indexed citations

Castillo‐Ecija, Helena, Jing Liu, Sara Pérez‐Jaume, et al.. (2022). Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients. The Journal of Pathology Clinical Research. 9(1). 32–43. 3 indexed citations

Clemente, Emilio J. Inarejos, Oscar M. Navarro, María Navallas, et al.. (2022). Multiparametric MRI evaluation of bone sarcomas in children. Insights into Imaging. 13(1). 33–33. 14 indexed citations

Garcia-Gerique, Laura, Marta García, Soledad Gómez‐González, et al.. (2022). MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment. BMC Cancer. 22(1). 669–669. 18 indexed citations

Pascual‐Pasto, Guillem, Helena Castillo‐Ecija, Nora Unceta, et al.. (2021). SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas. Journal of Controlled Release. 342. 81–92. 30 indexed citations

Baroni, Lorena, Carlos Rugilo, Fabiana Lubieniecki, et al.. (2020). Treatment response of CNS high‐grade neuroepithelial tumors with MN1 alteration. Pediatric Blood & Cancer. 67(12). e28627–e28627. 6 indexed citations

10.

Clemente, Emilio J. Inarejos, María Navallas, Ignasi Barber, et al.. (2020). MRI of Rhabdomyosarcoma and Other Soft-Tissue Sarcomas in Children. Radiographics. 40(3). 791–814. 43 indexed citations

11.

Botteri, Gaia, Helena Castillo‐Ecija, Guillem Pascual‐Pasto, et al.. (2018). Tissue Compatibility of SN‐38‐Loaded Anticancer Nanofiber Matrices. Advanced Healthcare Materials. 7(15). e1800255–e1800255. 5 indexed citations

12.

Pascual‐Pasto, Guillem, Nagore G. Olaciregui, Javier A.W. Opezzo, et al.. (2017). Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier. Journal of Controlled Release. 264. 34–44. 8 indexed citations

13.

Pascual‐Pasto, Guillem, Nagore G. Olaciregui, Mònica Vilà-Ubach, et al.. (2016). Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination. Cancer Letters. 380(1). 10–19. 24 indexed citations

14.

Mora, Jaume, Ofelia Cruz, Cinzia Lavarino, et al.. (2015). Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7). Clinical & Translational Oncology. 17(7). 521–529. 10 indexed citations

15.

García, Idoia, José Ríos, Gema Doménech, et al.. (2012). A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma. Clinical Cancer Research. 18(7). 2012–2023. 51 indexed citations

16.

Arias, Daniel Palanca, Àngels García‐Cazorla, Cristina Jou, et al.. (2012). cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period. JIMD Reports. 8. 57–62. 6 indexed citations

17.

Krauel, Lucas, et al.. (2010). Transitional cell carcinoma of the bladder in children and adolescents: Six-case series and review of the literature. Journal of Pediatric Urology. 6(5). 481–485. 50 indexed citations

18.

García, Idoia, Eva Rodríguez, Mariona Suñol, et al.. (2010). Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. Molecular Cancer. 9(1). 277–277. 52 indexed citations

19.

Krauel, Lucas, et al.. (2008). Median Raphe Cysts of the Perineum in Children. Urology. 71(5). 830–831. 30 indexed citations

20.

Tovar, Juan A., et al.. (1987). Hodgkin's disease of the thymus: A rare mediastinal cystic mass. Journal of Pediatric Surgery. 22(11). 996–997. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact